Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Prepaid Assets: 2020-2025

Historic Prepaid Assets for Relay Therapeutics (RLAY) over the last 6 years, with Sep 2025 value amounting to $23.8 million.

  • Relay Therapeutics' Prepaid Assets rose 27.31% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 million, marking a year-over-year increase of 27.31%. This contributed to the annual value of $17.3 million for FY2024, which is 3.87% up from last year.
  • Latest data reveals that Relay Therapeutics reported Prepaid Assets of $23.8 million as of Q3 2025, which was up 48.62% from $16.0 million recorded in Q2 2025.
  • Relay Therapeutics' 5-year Prepaid Assets high stood at $23.8 million for Q3 2025, and its period low was $5.6 million during Q2 2021.
  • For the 3-year period, Relay Therapeutics' Prepaid Assets averaged around $16.0 million, with its median value being $16.7 million (2023).
  • Per our database at Business Quant, Relay Therapeutics' Prepaid Assets skyrocketed by 128.35% in 2022 and then dropped by 27.02% in 2023.
  • Relay Therapeutics' Prepaid Assets (Quarterly) stood at $11.5 million in 2021, then climbed by 5.63% to $12.1 million in 2022, then soared by 37.92% to $16.7 million in 2023, then increased by 3.87% to $17.3 million in 2024, then grew by 27.31% to $23.8 million in 2025.
  • Its Prepaid Assets was $23.8 million in Q3 2025, compared to $16.0 million in Q2 2025 and $22.0 million in Q1 2025.